707 filings
Page 23 of 36
4
Emster Kurt Von
19 Dec 18
CRISPR Therapeutics / KURT VON EMSTER ownership change
4:22pm
4
CRSP
CRISPR Therapeutics AG
11 Dec 18
CRISPR Therapeutics / Samarth Kulkarni ownership change
4:29pm
4
Samarth Kulkarni
3 Dec 18
CRISPR Therapeutics / Samarth Kulkarni ownership change
5:29pm
CT ORDER
CRSP
CRISPR Therapeutics AG
30 Nov 18
Confidential treatment order
11:08am
424B5
CRSP
CRISPR Therapeutics AG
9 Nov 18
Prospectus supplement for primary offering
12:00am
8-K
CRSP
CRISPR Therapeutics AG
9 Nov 18
Other Events
12:00am
8-K
CRSP
CRISPR Therapeutics AG
7 Nov 18
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results
5:22pm
10-Q
2018 Q3
CRSP
CRISPR Therapeutics AG
Quarterly report
7 Nov 18
12:00am
8-K
CRSP
CRISPR Therapeutics AG
10 Oct 18
Regulation FD Disclosure
5:25pm
424B5
CRSP
CRISPR Therapeutics AG
24 Sep 18
Prospectus supplement for primary offering
8:23pm
8-K
CRSP
CRISPR Therapeutics AG
24 Sep 18
Entry into a Material Definitive Agreement
5:27pm
8-K
CRSP
CRISPR Therapeutics AG
21 Sep 18
Crispr Therapeutics Announces Proposed Public Offering of Common Shares
4:16pm
424B5
CRSP
CRISPR Therapeutics AG
21 Sep 18
Prospectus supplement for primary offering
4:10pm
424B5
CRSP
CRISPR Therapeutics AG
19 Sep 18
Prospectus supplement for primary offering
4:21pm
S-3ASR
CRSP
CRISPR Therapeutics AG
19 Sep 18
Automatic shelf registration
4:02pm
8-K
CRSP
CRISPR Therapeutics AG
17 Sep 18
CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes
12:00am
8-K
CRSP
CRISPR Therapeutics AG
11 Sep 18
Other Events
12:00am
4
CRSP
CRISPR Therapeutics AG
4 Sep 18
CRISPR Therapeutics / Samarth Kulkarni ownership change
12:00am
424B5
CRSP
CRISPR Therapeutics AG
31 Aug 18
Prospectus supplement for primary offering
12:00am
8-K
CRSP
CRISPR Therapeutics AG
31 Aug 18
Entry into a Material Definitive Agreement
12:00am